Targeting Endothelial Cell Anergy to Improve CAR T Cell Therapy for Solid Tumors

Investigators discuss how prior or concomitant treatment with an antiangiogenic drug can improve CAR T cell therapy, to become an attractive strategy for the treatment of solid tumors.